Development of novel NLRP3 inflammasome inhibitors and their potential application

被引：0
|
作者：
Zhang, Shijun [1 ]
Chojnacki, Jeremy [2 ]
Marchetti, Carlo [2 ]
Toldo, Stefano [2 ]
Abbate, Antonio [2 ]
机构：
[1] Virginia Commonwealth Univ, Med Chem, Richmond, VA USA
[2] Virginia Commonwealth Univ, Richmond, VA USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2015年 / 249卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
15
引用
收藏
页数：1
相关论文
共 50 条
  • [21] A novel regulator of NLRP3 inflammasome: Peptides
    Zuo, Zhuo
    Wang, Yaxing
    Fang, Yanwei
    Zhao, Mengya
    Wang, Zhe
    Yang, Zhouqi
    Jia, Bin
    Sun, Yulong
    PEPTIDES, 2025, 187
  • [22] A novel mechanism for NLRP3 inflammasome activation
    Zhang, Tan
    Zhao, Jingyao
    Liu, Tiemin
    Cheng, Wei
    Wang, Yibing
    Ding, Shuzhe
    Wang, Ru
    METABOLISM OPEN, 2022, 13
  • [23] Editorial: Novel perspectives on the NLRP3 inflammasome
    Liang, Ying
    Hua, Kuo-Feng
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [24] SHARPIN, a novel regulator of the NLRP3 inflammasome
    Gurung, Prajwal
    Kanneganti, Thirumala-Devi
    JOURNAL OF IMMUNOLOGY, 2015, 194
  • [25] NLRP3 INFLAMMASOME
    Shen, Jianxiao
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2016, 31 : 404 - 404
  • [26] MCC950 is a potent and specific inhibitor of the NLRP3 inflammasome and a novel potential therapeutic for NLRP3 driven diseases
    Coll, Rebecca C.
    Robertson, Avril A. B.
    Chae, Jae Jin
    Higgins, Sarah C.
    Dungan, Lara S.
    Munoz-Planillo, Raul
    Monks, Brian G.
    Croker, Daniel E.
    Sutton, Caroline E.
    Stutz, Andrea
    Nunez, Gabriel
    Latz, Eicke
    Kastner, Daniel L.
    Mills, Kingston H. G.
    Masters, Seth L.
    Schroder, Kate
    Cooper, Matt A.
    O'Neill, Luke A. J.
    CYTOKINE, 2014, 70 (01) : 35 - 35
  • [27] Design, synthesis and biological evaluation of novel diphenylamine analogues as NLRP3 inflammasome inhibitors
    Kang, Tongtong
    Sun, Simin
    Wang, Huimin
    Liu, Jinyu
    Li, Xiaoyang
    Jiang, Yuqi
    BIOORGANIC & MEDICINAL CHEMISTRY, 2024, 113
  • [28] Novel Macrocyclic NLRP3 Inhibitors
    Mesch, Stefanie
    Shannon, Jonathan
    Miller, David
    Macleod, Angus
    Bouche, Lea
    Johnston, Heather J.
    Matthews, Kim
    Paehler, Axel
    Best, Stuart
    Guba, Wolfgang
    Alanine, Thomas
    Halai, Reena
    Charge, Lorna
    Garside, Samantha
    Thom, Stephen
    Incerti-Pradillos, Celia
    Mcpherson, Christopher
    Carrillo, Jokin
    St-Gallay, Steve
    Rigo, Pierre
    Schlicht, Sonja
    Hendrick, Alan G.
    Lerner, Christian
    Piali, Luca
    Blaising, Julie
    Mracsko, Eva Z.
    Jaeschke, Georg
    Cooper, Matthew A.
    JOURNAL OF MEDICINAL CHEMISTRY, 2024, 67 (23) : 20911 - 20932
  • [29] Discovery of Novel NLRP3 Inflammasome Inhibitors Composed of an Oxazole Scaffold Bearing an Acylsulfamide
    Ohba, Yusuke
    Adachi, Kaoru
    Furukawa, Takayuki
    Nishimaru, Tatsuya
    Sakurai, Kentaro
    Masuo, Ritsuki
    Inami, Tasuku
    Orita, Takuya
    Akai, Shota
    Adachi, Tsuyoshi
    Usui, Kenji
    Hamada, Yuji
    Mori, Mutsuki
    Kurimoto, Takafumi
    Wakashima, Takeshi
    Akiyama, Yoshiyuki
    Miyazaki, Susumu
    Noji, Satoru
    ACS MEDICINAL CHEMISTRY LETTERS, 2023, 14 (12): : 1833 - 1838
  • [30] The NLRP3 inflammasome in depression: Potential mechanisms and therapies
    Xia, Cong-Yuan
    Guo, Yu-Xuan
    Lian, Wen-Wen
    Yan, Yu
    Ma, Bing-Zhi
    Cheng, Yung -Chi
    Xu, Jie-Kun
    He, Jun
    Zhang, Wei -Ku
    PHARMACOLOGICAL RESEARCH, 2023, 187
12345